Abrdn Life Science Investors (NASDAQ:HQL) | Finanzwire

Basculer en Français

10443	Companies
219230	Keywords
148691	Articles
115967	Press releases

Headlines Articles Press releases Abrdn Life Science Investors

Home
Companies
Abrdn Life Science Investors

PRESS RELEASE

published on 02/09/2024 at 23:23, 2 years 3 months ago

abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate
abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) have approved an increase in each Fund's distribution rate and announce payment details for the Funds. The Boards consider strong long term positive total return and the outlook on the healthcare sector

Healthcare Sector Abrdn Life Sciences Investors Abrdn Healthcare Investors Abrdn Healthcare Opportunities Fund Distribution Rate

Accesswire

Published on 05/23/2026 at 03:00, 1 minute ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 36 minutes ago

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 36 minutes ago

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 2 hours 1 minute ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/23/2026 at 00:55, 2 hours 6 minutes ago

GLG Life Tech Corporation Reports 2026 First Quarter Financial Results

View all ACCESSWIRE

EQS Group

Published on 05/22/2026 at 22:05, 4 hours 56 minutes ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 7 hours 9 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 8 hours 28 minutes ago

Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 8 hours 31 minutes ago

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 18:29, 8 hours 32 minutes ago

Designated Person Notification

Les Echos

Published on 05/22/2026 at 18:05, 8 hours 55 minutes ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 14 hours 8 minutes ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 18 hours 31 minutes ago

Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/21/2026 at 17:50, 1 day 9 hours ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 1 day 9 hours ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE